Unrelated umbilical cord blood can improve the prognosis of haploidentical hematopoietic stem cell transplantation

Ying Yang,Ming Zhang,Mengqi Li,Yingchun Li,Wei Yang,Zhuogang Liu,Hongtao Wang

DOI: https://doi.org/10.1186/s13287-022-03170-x

2022-09-25

Abstract:Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) is widely used as a curative treatment strategy for most types of hematological diseases. However, strategies for enhancing the graft versus leukemia (GVL) effect without aggravating the graft versus host disease (GVHD) effect are still being pursued.

cell biology,medicine, research & experimental,cell & tissue engineering